Previously post-focus compression (PFC) - the lowering of fundamental frequency (F0) and intensity of post-focal words to below those of the same words in identical sentences with neutral focus - was found in Beijing Mandarin but not in Taiwan Southern Min and Taiwan Mandarin. This study investigated whether the presence of PFC would vary with age and language use of societal bilinguals of Southern Min and Mandarin. Three groups of bilingual speakers of Quanzhou Southern Min and Mandarin, age around 20, 40 and 60, were examined for their prosodic realization of focus. All the speakers acquired Southern Min first, followed by Mandarin in childhood, but the younger speakers used more Mandarin than the older speakers. Comparisons of duration, intensity and F0 in focused, prefocus and post-focus words indicated that all groups produced Taiwan-like focus, i.e., without PFC, in Southern Min, but the youngest group produced Beijing-like PFC in Mandarin. These findings reveal that increased language experience, such as greater amount of second language (L2) use, correlates with increased ability to produce native-like PFC in L2, suggesting that PFC can be used as an indicator in assessing L2 speech acquisition.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.